Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NxCare and ERSP

This article was originally published in The Tan Sheet

Executive Summary

NxCare is asked by the Electronic Retailing Self-Regulatory Program to discontinue product superiority claims and modify weight-loss related performance claims for its Methyl Ripped fat burner product in a decision announced Dec. 8. Claims reviewed by ERSP include: "Bodybuilding's strongest fat burner" and "Methyl Ripped's formula goes to work quickly obliterating fat." The watchdog program determined NxCare's submitted testing results did not adequately support "all reasonable interpretations" communicated by the claims and recommended modifying or discontinuing them. ERSP also recommends NxCare increase the text size of disclosure language accompanying consumer testimonials to be made "more clear and conspicuous"...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100034

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel